Worth Asset Management LLC decreased its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 40.4% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,609 shares of the company’s stock after selling 1,089 shares during the quarter. Worth […]

Verde Servicos Internacionais S.A. purchased a new position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) in the 1st quarter, according to the company in its most recent filing with the SEC. The fund purchased 2,000 shares of the company’s stock, valued at approximately $1,840,000. Eli Lilly and Company accounts for approximately […]

FFG Partners LLC bought a new stake in Eli Lilly and Company (NYSE:LLY – Free Report) in the first quarter, HoldingsChannel.com reports. The firm bought 3,891 shares of the company’s stock, valued at approximately $3,580,000. Eli Lilly and Company accounts for 1.4% of FFG Partners LLC’s portfolio, making the stock its 18th biggest position. Several […]

PeakShares LLC acquired a new stake in shares of Eli Lilly and Company (NYSE:LLY – Free Report) during the fourth quarter, HoldingsChannel reports. The firm acquired 1,020 shares of the company’s stock, valued at approximately $1,096,000. Eli Lilly and Company accounts for approximately 1.1% of PeakShares LLC’s portfolio, making the stock its 26th largest holding. […]

BNB Wealth Management LLC bought a new stake in Eli Lilly and Company (NYSE:LLY – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 766 shares of the company’s stock, valued at approximately $823,000. Other large investors have also recently made changes to […]

Aptus Capital Advisors LLC lessened its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 77.8% during the 4th quarter, Holdings Channel.com reports. The firm owned 56,671 shares of the company’s stock after selling 198,123 shares during the quarter. Aptus Capital Advisors LLC’s holdings in Eli Lilly and Company were worth $60,904,000 as […]

Rhenman & Partners Asset Management AB lessened its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 21.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 42,220 shares of the company’s stock after selling 11,200 shares during the quarter. Eli Lilly […]